The IPKat is also happy to report that it has negotiated a 20% discount in the registration fee with the organizers of the conference (the Katfriends of the Academy of European Law (ERA) based in beautiful Trier).
This year, the conference will introduce the latest changes of the EU Pharma package adopted by the Council and the Parliament last December and will look at their impact in the pharma sector. The most favoured nation principle and its consequences on access to medicines in the EU will be explained. The new Strategy for European Life Science (Biotech Act, European Innovation Act, and omnibus initiatives) will be at the heart of the discussion too. Finally, a strong focus will be made on the multiple legal aspects and the great potential offered by AI in the pharma and health sectors.
Aimed at in-house counsel, lawyers in private practice, lawyers in national ministries and authorities dealing with regulation of the sector, this hybrid conference will bring attendees up to date on the latest regulatory developments, legislative initiatives and case law.
Looking at the
programme, the speakers have been selected from a variety of backgrounds – representing EU institutions, companies, trade bodies, law firms, and academia alike – thus ensuring a broad coverage of the various perspectives on the issues at the centre of this year’s edition.
As mentioned, IPKat readers are entitled to a 20% discount using the VIP code
IPKAT2026ERA at checkout (it can be combined with the early bird discount where applicable). For further information and to register,
click here.
